187 related articles for article (PubMed ID: 32709978)
1. Crosstalk between COVID-19 and prostate cancer.
Bahmad HF; Abou-Kheir W
Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):561-563. PubMed ID: 32709978
[TBL] [Abstract][Full Text] [Related]
2. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).
Montopoli M; Zumerle S; Vettor R; Rugge M; Zorzi M; Catapano CV; Carbone GM; Cavalli A; Pagano F; Ragazzi E; Prayer-Galetti T; Alimonti A
Ann Oncol; 2020 Aug; 31(8):1040-1045. PubMed ID: 32387456
[TBL] [Abstract][Full Text] [Related]
3. Relative Timing of Radiotherapy and Androgen Deprivation for Prostate Cancer and Implications for Treatment During the COVID-19 Pandemic.
Dee EC; Mahal BA; Arega MA; D'Amico AV; Mouw KW; Nguyen PL; Muralidhar V
JAMA Oncol; 2020 Oct; 6(10):1630-1632. PubMed ID: 32789489
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 and androgen-targeted therapy for prostate cancer patients.
Bhowmick NA; Oft J; Dorff T; Pal S; Agarwal N; Figlin RA; Posadas EM; Freedland SJ; Gong J
Endocr Relat Cancer; 2020 Sep; 27(9):R281-R292. PubMed ID: 32508311
[TBL] [Abstract][Full Text] [Related]
5. The management of patients with metastatic prostate cancer during the COVID-19 pandemic.
Assi T; Ibrahim N; K Abboud RM; Kattan C; Rassy E; Nemr E; Kattan J
Future Oncol; 2020 Jul; 16(20):1455-1461. PubMed ID: 32412310
[TBL] [Abstract][Full Text] [Related]
6. [Can androgen deprivation therapy play a protective role in SARS-CoV-infections?].
Schlack K; Krabbe LM
Urologe A; 2020 Oct; 59(10):1251-1253. PubMed ID: 32776230
[No Abstract] [Full Text] [Related]
7. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.
Matsuyama S; Nao N; Shirato K; Kawase M; Saito S; Takayama I; Nagata N; Sekizuka T; Katoh H; Kato F; Sakata M; Tahara M; Kutsuna S; Ohmagari N; Kuroda M; Suzuki T; Kageyama T; Takeda M
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7001-7003. PubMed ID: 32165541
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Surgical Assistance in Prostate Cancer during the COVID-19 Pandemic: Implementation of assistance protocols.
Sanchez LR; Cathelineau X; Pinto AMA; Borque-Fernando Á; Gil MJ; Yee CH; Sanchez-Salas R
Int Braz J Urol; 2020 Jul; 46(suppl.1):50-61. PubMed ID: 32549073
[TBL] [Abstract][Full Text] [Related]
9. Dermatology staff participate in fight against Covid-19 in China.
Zheng Y; Lai W
J Eur Acad Dermatol Venereol; 2020 May; 34(5):e210-e211. PubMed ID: 32201983
[No Abstract] [Full Text] [Related]
10. Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection during late pregnancy: a report of 18 patients from Wuhan, China.
Zhang L; Dong L; Ming L; Wei M; Li J; Hu R; Yang J
BMC Pregnancy Childbirth; 2020 Jul; 20(1):394. PubMed ID: 32641013
[TBL] [Abstract][Full Text] [Related]
11. Importance of Environmental Factors on Production of Computationally- Defined Natural Molecules against COVID-19 Pandemic.
Abouleish M; El-Keblawy A; Mosa KA; Soliman SSM
Curr Top Med Chem; 2020; 20(22):1958-1961. PubMed ID: 33040729
[No Abstract] [Full Text] [Related]
12. Infections without borders: a new coronavirus in Wuhan, China.
Wood C
Br J Nurs; 2020 Feb; 29(3):166-167. PubMed ID: 32053437
[No Abstract] [Full Text] [Related]
13. HIV and SARS-CoV-2: points to consider to face this new pandemic.
Prieto Pozo AA; Salvador Sagüez FLD
Medwave; 2020 Oct; 20(9):e8049. PubMed ID: 33141814
[TBL] [Abstract][Full Text] [Related]
14. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
[TBL] [Abstract][Full Text] [Related]
15. Further explanations for the eq. (3) in "Estimating the daily trend in the size of the COVID-19 infected population in Wuhan".
Lin QS; Hu TJ; Zhou XH
Infect Dis Poverty; 2020 Sep; 9(1):129. PubMed ID: 32933588
[TBL] [Abstract][Full Text] [Related]
16. Does hydroxychloroquine combat COVID-19? A timeline of evidence.
Alia E; Grant-Kels JM
J Am Acad Dermatol; 2020 Jul; 83(1):e33-e34. PubMed ID: 32283236
[No Abstract] [Full Text] [Related]
17. The COVID-19 Pandemic from an Ophthalmologist's Perspective.
Bacherini D; Biagini I; Lenzetti C; Virgili G; Rizzo S; Giansanti F
Trends Mol Med; 2020 Jun; 26(6):529-531. PubMed ID: 32470381
[TBL] [Abstract][Full Text] [Related]
18. Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis.
Sari Motlagh R; Abufaraj M; Karakiewicz PI; Rajwa P; Mori K; Mun DH; Shariat SF
World J Urol; 2022 Apr; 40(4):907-914. PubMed ID: 34477955
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy in the era of COVID-19.
Lancia A; Bonzano E; Bottero M; Camici M; Catellani F; Ingrosso G
Expert Rev Anticancer Ther; 2020 Aug; 20(8):625-627. PubMed ID: 32552073
[No Abstract] [Full Text] [Related]
20. Outcomes in Radiotherapy-Treated Patients With Cancer During the COVID-19 Outbreak in Wuhan, China.
Xie C; Wang X; Liu H; Bao Z; Yu J; Zhong Y; Chua MLK
JAMA Oncol; 2020 Sep; 6(9):1457-1459. PubMed ID: 32729893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
